Search

Your search keyword '"Fertakis A"' showing total 5 results
Start Over Author "Fertakis A" Journal european urology
5 results on '"Fertakis A"'

1. Group-specific component and haptoglobin phenotypes in urinary calculous disease

Author

Anastasios E. Germenis, A. Babionitakis, Goulandris N, C. Dimopoulos, and A. Fertakis

Subjects
biology, Haptoglobins, business.industry, Urology, Urinary system, Vitamin D-Binding Protein, Haptoglobin, Disease, Phenotype, Gene Frequency, GROUP-SPECIFIC COMPONENT, Immunology, biology.protein, Medicine, Humans, Urinary Calculi, business, Carrier Proteins
Published
1982

4. Genetic Markers in Carcinoma of the Prostate

Author

Savides P, A. Fertakis, Anastasios E. Germenis, C. Dimopoulos, Meletios A. Dimopoulos, and Karayanis A

Subjects
Genetic Markers, Male, Pathology, medicine.medical_specialty, Urology, Malignancy, Gene Frequency, Prostate, medicine, Carcinoma, Humans, chemistry.chemical_classification, Haptoglobins, biology, business.industry, Vitamin D-Binding Protein, Haptoglobin, Transferrin, Prostatic Neoplasms, Complement C3, Hyperplasia, medicine.disease, Phenotype, medicine.anatomical_structure, chemistry, Genetic marker, Cancer research, biology.protein, business
Abstract

The distribution of phenotypes and gene frequencies of the third component of complement (C3), group-specific component (Gc), haptoglobin (Hp) and transferrin (Tf) were studied in 115 patients with carcinoma of the prostate. The statistical analysis of our findings in comparison to the frequency of these genes in a control group of 155 patients with benign prostatic hyperplasia does not reveal any correlation between the distribution of the Hp and Tf phenotypes and the disease. On the contrary, a statistically significant association was found between carcinoma of prostate and C3F and Gc2 genes. The relative risk incidence of this malignancy is 1.56 and 1.81, respectively, for the carriers of these genes suffering from benign prostate hyperplasia.

Published
1984

5. Genetic markers in carcinoma of the prostate.

Author

Dimopoulos MA, Germenis A, Savides P, Karayanis A, Fertakis A, and Dimopoulos C

Subjects
Complement C3 genetics, Gene Frequency, Haptoglobins genetics, Humans, Male, Phenotype, Transferrin genetics, Vitamin D-Binding Protein genetics, Genetic Markers, Prostatic Neoplasms genetics
Abstract

The distribution of phenotypes and gene frequencies of the third component of complement (C3), group-specific component (Gc), haptoglobin (Hp) and transferrin (Tf) were studied in 115 patients with carcinoma of the prostate. The statistical analysis of our findings in comparison to the frequency of these genes in a control group of 155 patients with benign prostatic hyperplasia does not reveal any correlation between the distribution of the Hp and Tf phenotypes and the disease. On the contrary, a statistically significant association was found between carcinoma of prostate and C3F and Gc2 genes. The relative risk incidence of this malignancy is 1.56 and 1.81, respectively, for the carriers of these genes suffering from benign prostate hyperplasia.

Published
1984
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results